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Naive T cells respond to antigen stimulation by
exiting from quiescence and initiating clonal expan-
sion and functional differentiation, but the control
mechanism is elusive. Here we describe that
Raptor-mTORC1-dependent metabolic reprogram-
ming is a central determinant of this transitional
process. Loss of Raptor abrogated T cell priming
and T helper 2 (Th2) cell differentiation, although
Raptor function is less important for continuous
proliferation of actively cycling cells. mTORC1 coor-
dinated multiple metabolic programs in T cells
including glycolysis, lipid synthesis, and oxidative
phosphorylation to mediate antigen-triggered exit
from quiescence. mTORC1 further linked glucose
metabolism to the initiation of Th2 cell differentiation
by orchestrating cytokine receptor expression and
cytokine responsiveness. Activation of Raptor-
mTORC1 integrated T cell receptor and CD28
costimulatory signals in antigen-stimulated T cells.
Our studies identify a Raptor-mTORC1-dependent
pathway linking signal-dependent metabolic reprog-
ramming to quiescence exit, and this in turn coordi-
nates lymphocyte activation and fate decisions in
adaptive immunity.
INTRODUCTION
Mature T cells circulate through peripheral lymphoid organs in a
quiescent state (G0) characterized by small cell size and low
metabolic activity (Hamilton and Jameson, 2012). Antigen stim-
ulation through T cell receptors (TCRs) activates T cells, leading
to clonal expansion and effector differentiation. Associated with
T cell activation is a marked increase of metabolic activities such
as glycolysis (Wang and Green, 2012). Despite extensive knowl-
edge on early TCR signaling (e.g., NF-kB and MAPK activation)Immand subsequent clonal expansion and differentiation, how these
processes are connected remains unclear. One notable feature
of this transitional period is the extended time required
(>24 hr), as compared with subsequent cell divisions that involve
rapid doubling (every 5–6 hr) (Rowell and Wells, 2006). However,
little is understood about the mechanisms whereby naive T cells
transit from quiescence to the entry of the first cell cycle or the
extent to which this transitional process impacts ensuing clonal
expansion and functional differentiation.
The mechanistic target of rapamycin (mTOR) pathway is a
crucial regulator of T cell responses (Chi, 2012). mTOR signaling
is composed of mTORC1 and mTORC2 complexes defined
by the signature components Raptor and Rictor, respectively.
Blocking mTORC1 by rapamycin exerts antiproliferative and
other immune-suppressive effects. However, rapamycin-resis-
tant proliferation has been observed in various T cell populations
(Finlay et al., 2012; Fox et al., 2005), and rapamycin can even
promote immune responses in select conditions (Araki et al.,
2009). Notably, rapamycin can blockmTORC2 activity upon pro-
longed or high-dose treatment in CD4+ T cells (Delgoffe et al.,
2011) but not in effector CD8+ T cells (Finlay et al., 2012). Addi-
tionally, rapamycin is not an efficient inhibitor of mTORC1-medi-
ated 4E-BP1 phosphorylation (Choo et al., 2008). Moreover,
because of the broad effects of rapamycin onmultiple cell types,
use of rapamycin in vivo is unlikely to reveal T cell-intrinsic
requirement of mTOR. Instead, T cell-specific deletion systems
have been instrumental in dissecting the specific roles of
mTOR in T cell responses. In CD4+ T cells, loss of Rheb, an
important upstream activator of mTORC1, inhibits the differenti-
ation of T helper 1 (Th1) and Th17 effector cells (Delgoffe et al.,
2009; Delgoffe et al., 2011), whereas deletion of Raptor impairs
Th17 cell differentiation (Kurebayashi et al., 2012). Further,
Th2 cell differentiation has been shown to require mTORC2
activity (Delgoffe et al., 2011; Lee et al., 2010), independent of
Rheb-dependent mTORC1 (Delgoffe et al., 2011). Finally,
T cells lacking Rheb exhibit modestly reduced proliferation and
normal interleukin-2 (IL-2) production that suggest a limited
role of mTORC1 in early T cell priming (Delgoffe et al., 2011).
However, it is important to note that multiple upstream inputs
feed into mTORC1, some of which are independent of Rheb orunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier Inc. 1043
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mTORC1 in Metabolic Programming of Quiescence ExitPI3K-AKT (Finlay et al., 2012; Gwinn et al., 2008). Also, Rheb has
nonconventional activities independently of mTORC1 (Neuman
and Henske, 2011), highlighting the complexity of mTORC1
regulation. Furthermore, although the metabolic function of
mTORC1 is well recognized (Du¨vel et al., 2010), little is under-
stood about how this is regulated in T cells (Zeng and Chi,
2013). Altogether, the physiological significance and mecha-
nistic basis of mTORC1 in T cell functions remain controversial
and unclear.
Capitalizing on genetic deletion of Raptor, here we report that
mTORC1 is a central regulator of adaptive immunity. Among
components of mTOR signaling tested, Raptor has a predomi-
nant role in regulating T cell priming and in vivo immune re-
sponses, whereas Rictor-mTORC2 and Rheb exert more
modest effects. Mechanistically, Raptor-mTORC1 orchestrates
the glycolytic and lipogenic programs to drive the exit of naive
T cells from the quiescent G0 state. Further, Raptor-mediated
metabolic reprogramming plays a central role in instructing Th2
cell differentiation, by integrating TCR and CD28 signals and
coupling them to cytokine responsiveness. Our studies identify
a Raptor-mTORC1-mediated pathway linking signal-dependent
metabolic reprogramming to quiescence exit, and this in turn
coordinates cell proliferation and fate decisions.
RESULTS
Raptor Deletion Impairs T Cell Activation and
Proliferation
To investigate the roles of Raptor in T cell functions, we crossed
mice with loxP-flanked Rptor alleles (Rptorfl/fl) with CD4-Cre
mice to delete Rptor specifically in T cells (called ‘‘Rptor/’’;
Figures S1A and S1B). Wild-type (WT) and Rptor/ mice had
similar numbers of total thymocytes and major subsets (Fig-
ure S1C). Peripheral CD4+ T cells in Rptor/ mice were undis-
turbed, whereas CD8+ T cells showed a modest reduction in
the spleen (Figure 1A) and lymph nodes (data not shown).
Further, Rptor/ mice contained a reduced CD62LloCD44hi
population with an activation or memory phenotype, especially
in CD8+ cells (Figure 1B). Thus, Raptor contributes to homeosta-
sis of peripheral T cells, especially CD8+ cells, under steady
state.
Antigen stimulation induces activation and clonal expansion of
naive T cells. We analyzed TCR-induced initial activation and
ensuing proliferation in Rptor/ naive CD4+ T cells (CD62Lhi
CD44loCD25–; unless otherwise noted, naive T cells were used
throughout this study). IL-2 production, a hallmark of T cell acti-
vation, was substantially reduced in Rptor/ T cells stimulated
with TCR and CD28 (Figures 1C and 1D). Following stimulation
with a-CD3 or a-CD3-CD28, WT cells underwent proliferation
as measured by [3H]thymidine incorporation. However, greatly
reduced proliferation was observed in Rptor/CD4+ (Figure 1E)
and CD8+ T cells (Figure S1D). To distinguish the contribution
from cell death and division, wemeasured these two effects spe-
cifically by tracking incorporation of propidium iodide (PI) and
dilution of CFSE. WT and Rptor/ T cells showed comparable
survival in the presence or absence of TCR stimulation (Fig-
ure S1E). In contrast, whereas CFSE-labeledWT cells underwent
robust division after 72 hr of TCR stimulation, the division of
Rptor/ T cells wasmarkedly reduced (Figure 1F). Furthermore,1044 Immunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier Inthe proliferative defect of Rptor/ T cells was not secondary to
impaired IL-2 production because exogenous IL-2 did not
restore the proliferation (Figure S1F). These results establish
the crucial function of Raptor in TCR-induced activation and pro-
liferation in vitro.
To address the role of Raptor in vivo, we crossed Raptor defi-
ciency onto the OT-II TCR-transgenic mouse model, which
allowed us to visualize proliferation of antigen-specific T cells
in vivo. We sorted naive T cells from WT OT-II and Rptor/
OT-II mice, labeled them with CFSE, and transferred them into
congenic CD45.1+ mice, followed by s.c. immunization with
OVA323–339 peptide. At 72 hr following immunization, Rptor
/
OT-II donor cells showed much less accumulation in the
recipients’ draining lymph nodes (Figure 1G), associated with
markedly reduced CFSE dilution and cell growth (Figure 1H).
Therefore, Raptor function is crucial for antigen-induced T cell
proliferation in vivo.
Aside from antigen-induced proliferation, transfer of naive
T cells into lymphopenic environment also initiates rapid prolifer-
ation. Such proliferative responses involve distinct metabolic re-
quirements from antigen-specific proliferation (Kidani et al.,
2013; Sena et al., 2013) and can be further divided into homeo-
static and spontaneous proliferation (Kieper et al., 2005; Min
et al., 2005). To determine the role of Raptor in lymphopenia-
induced proliferation, we transferred CFSE-labeled naive
T cells into sublethally irradiated CD45.1+ or unmanipulated
Rag1/ mice to trigger homeostatic or spontaneous prolifera-
tion, respectively (Kieper et al., 2005; Min et al., 2005). Rptor/
donor T cells showed marked defects of proliferation in both
types of recipients (Figures 1I and 1J). Notably, Raptor deletion
did not affect cell survival under steady state (data not shown)
or upon in vitro stimulation with IL-7 (Figure S1G). These findings
collectively indicate that Raptor is essential for both antigen-
specific and lymphopenia-induced proliferation.
ACentral Role of Raptor, but Not Rictor, in TCell Priming
To determine the role of Raptor in immune responses in vivo, we
infected WT and Rptor/mice with recombinant Listeria mono-
cytogenes expressing ovalbumin (OVA). CD4+ T cells from in-
fected Rptor/ mice contained a greatly reduced proportion
of antigen-specific interferon-g+ (IFN-g+) cells following restimu-
lation with LLO189–201 peptide (Figures 2A and 2B). Rptor
/
mice also had markedly reduced IFN-g+ CD8+ T cells after
OVA257–264 restimulation (Figures 2C and 2D). Additionally,
CD8+ T cells from infected Rptor/mice had significantly fewer
tetramer-positive cells than did those from controls (Figures S2A
and S2B). Thus, Raptor deletion essentially abolished antibacte-
rial immune responses in vivo.
Given the frequent cross-regulation of mTORC1 andmTORC2
activities (Zoncu et al., 2011), we examined the effect of
mTORC2 in anti-Listeria immune responses by analyzing mice
with CD4-Cre-mediated deletion of Rictor to ablate mTORC2
activity (Rictorfl/flCD4-Cre (Yang et al., 2011), called ‘‘Rictor/’’)
and Rptor/Rictor/ mice. Rictor/ mice showed a small
reduction in the generation of IFN-g+ cells (Figures 2A–2D), as
well as in the expansion of tetramer-positive T cells (Figures
S2A and S2B). Antigen-specific responses were blunted in
mice deficient in both mTOR complexes, and these effects
were largely comparable to the loss of Raptor alone (Figuresc.
Figure 1. Raptor Is Required for T Cell Activation and Proliferation In Vitro and In Vivo
(A) Flow cytometry of CD4+ and CD8+ T cells in the spleens of WT andRptor/mice. Right panels show proportions and numbers of CD4+ andCD8+ T cells (n = 3
mice per group).
(B) Expression of CD62L and CD44 on CD4+ and CD8+ T cells.
(C and D) IL-2 secretion (C) and mRNA expression (D) in CD4+ T cells stimulated with a-CD3-CD28.
(E) [3H]Thymidine incorporation of CD4+ T cells stimulated with a-CD3 or a-CD3-CD28 for 64 hr and pulsed with [3H]thymidine for an additional 8 hr.
(F) Flow cytometry of CFSE-labeled CD4+ T cells stimulated with a-CD3-CD28 for 72 hr.
(G and H) CFSE-labeled WT OT-II or Rptor/ OT-II T cells (CD45.2+) were transferred into CD45.1+ recipients and immunized s.c. with OVA323–339 in CFA 24 hr
later, followed by analysis after an additional 3 days. (G) shows proportion and number of donor OT-II T cells in the draining lymph nodes of recipients (n = 3 mice
per group). (H) shows flow cytometry of CFSE (left) and cell size (right) of donor OT-II T cells.
(I and J) CFSE-labeled CD4+ T cells were transferred into sublethally irradiated CD45.1+ (I) or non-irradiated Rag1/mice (J), followed by analysis at day 7 after
transfer. Data are representative of 2 (A-D,G-J) or 3 (E,F) independent experiments, and error bars represent the SEM. See also Figure S1.
Immunity
mTORC1 in Metabolic Programming of Quiescence Exit2A–2D; Figures S2A and S2B). Therefore, Raptor clearly plays a
predominant role in antibacterial immune responses.
We next compared the effects of Raptor and Rictor loss on
T cell proliferation in vitro. In contrast to the severely impaired
proliferation of Rptor/ T cells, the proliferative defect of
Rictor/ T cells was less profound especially when stimulated
with optimal a-CD3-CD28 antibodies (Delgoffe et al., 2011;
Lee et al., 2010) (Figure 2E). Similar results were observed
in antigen-specific OT-II T cells (Figure S2C). Further,
Rptor/Rictor/ and Rptor/ T cells showed a comparable
defect in proliferation (Figure 2E). Thus, in vivo priming and
in vitro proliferation of T cells have a more stringent requirement
of Raptor than Rictor function.ImmPreferential Requirement of Raptor for Cell-Cycle Entry
from Quiescence
We next determined the specific stage in cell proliferation that
requires Raptor-mTORC1 function. When T cells were stimu-
lated with a-CD3-CD28 for 24 hr and pulse-labeled with bromo-
deoxyuridine (BrdU), over 20% of WT cells incorporated BrdU.
However, less than 1% of Rptor/ cells accomplished this (Fig-
ure 3A), indicating a defect to enter S phase. TCR stimulation
also results in increased cell size, namely cell growth, which is
required for cell-cycle entry (Lea et al., 2003). Freshly isolated
Rptor/ naive T cells showed a slightly reduced cell size (Fig-
ure S3A). After TCR stimulation for 18 hr, WT cells were substan-





Figure 2. Deficiency of Raptor but Not Rictor Markedly Impairs Antigen-Specific Immune Responses In Vivo and In Vitro
(A and B) Flow cytometry of OVA-reactive IFN-g+ CD4+ T cells frommice infected with OVA-expressing L. monocytogenes, detected after LLO189–201 stimulation
and intracellular cytokine staining (A). (B) shows proportion and number of LLO-reactive IFN-g+ CD4+ T cells.
(C and D) Flow cytometry of OVA-reactive IFN-g+ CD8+ T cells from infected mice, detected after OVA257–264 stimulation and intracellular cytokine staining (C).
(D) shows proportion and number of OVA-reactive IFN-g+ CD8+ T cells.
(E) [3H]Thymidine incorporation of CD4+ T cells stimulated with a-CD3 or a-CD3-CD28 for 64 hr and pulsed with [3H]thymidine for an additional 8 hr. Data are
combined results from three (A–D) independent or representative of two (E) independent experiments, and error bars represent the SEM. See also Figure S2.
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regulated expression of amino-acid transporters that include
CD98 as a key component, and the transferrin receptor CD71
for iron uptake. Although expression of these receptors is in-
hibited by rapamycin (Edinger and Thompson, 2002), the relative
contributions frommTORC1 andmTORC2 are unclear. Rptor/
T cells showed marked defects in TCR-induced CD98 and CD71
expression, whereasRictor/ T cells exhibited nomajor defects
(Figure 3B). These data reveal a key role of Raptor in cell growth
and nutrient uptake that might contribute to cell-cycle entry.
To understand the mechanistic basis, we performed bio-
informatic analysis to identify Raptor-dependent pathways in
TCR and CD28-stimulated cells at 0, 8, and 24 hr. Remarkably,
out of the 901 probes (representing 594 individual genes) with
2-fold or greater difference (with false discovery rate, FDR <
0.05) at 24 hr, 212 probes (128 genes) were associated with
cell-cycle regulation and were downregulated in Rptor/ cells
(Figure 3C; Table S1). Next, to identify key networks regulated
by Raptor, we performed gene set enrichment analysis (GSEA)
to compare the transcriptomes of WT and Rptor/ T cells
without arbitrary cut-offs (Subramanian et al., 2005). This unbi-
ased analysis revealed that the cell-cycle-related pathways
constituted the top 10 most significantly downregulated gene
sets in Rptor/ T cells at 24 hr of stimulation (data not shown),
with the cell-cycle mitotic pathway as the top hit (Normalized
Enrichment Score, NES = –3.25, FDR < 0.001; Figure S3B). To1046 Immunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier Indissect detailed kinetics of Raptor-dependent cell-cycle entry,
we also analyzed gene-expression profiles at 0 and 8 hr of
TCR and CD28 stimulation. Whereas very few probes (46 in total)
were differentially expressed before activation (data not shown),
a total of 202 probes (126 genes) showed equal or greater than 2-
fold change (FDR < 0.05) between WT and Rptor/ T cells after
8 hr of stimulation (Table S2). Although fewer cell-cycle genes
were altered at 8 hr than at 24 hr by the 2-fold cut-off, GSEA anal-
ysis revealed that the genes involved in M/G1 transition of cell
cycle were significantly reduced in Rptor/ T cells (FDR =
–2.84, FDR < 0.001; Figure S3C). We next directly examined
whether Raptor loss affects the cell-cycle machinery. TCR and
CD28 stimulation of WT CD4+ T cells induced the expression
of cyclins D2 and E, and CDK2, CDK4 and CDK6, but this induc-
tion was diminished in Rptor/ cells (Figure 3D). Further, cyclin-
dependent phosphorylation of the cell-cycle regulator Rb, spe-
cifically at Ser807 and Ser811 (mediated by cyclin D–CDK4 or
CDK6) and Thr821 (cyclin E–CDK2), occurred after TCR stimula-
tion in WT cells but was greatly reduced in Rptor/ T cells (Fig-
ure 3E). Thus, Raptor deficiency impairs initiation of the cell-cy-
cle machinery in TCR-signaled cells.
Having established a role of Raptor in cell-cycle entry of naive
cells, we next tested whether Raptor was also required for the
proliferation of activated effector T cells. In contrary to naive
T cells that respond to antigens by entering cell cycle from quies-








Figure 3. Raptor-mTORC1 Signaling Is Mainly Required for Cell-Cycle Entry from Quiescence Instead of Continuous Proliferation
(A) BrdU staining of CD4+ T cells stimulated with a-CD3-CD28 for 22 hr, followed by pulsing with BrdU for 2 hr.
(B) Expression of CD71 and CD98 on CD4+ T cells stimulated with a-CD3-CD28 for 18 hr.
(C) Scatterplot comparing global gene-expression profiles between WT and Rptor/ CD4+ T cells stimulated with a-CD3-CD28 for 24 hr (n = 4 mice per group).
Probe sets containing the cell-cycle genes with 2-fold or greater difference between WT and Rptor/ T cells are shown in red, with select genes annotated.
mRNA expression levels are on a log2 scale.
(D) Expression of Raptor, cyclin D2, cyclin E, CDK2, CDK4, and CDK6 in CD4+ T cells stimulated with a-CD3-CD28.
(E) Expression and phosphorylation of Rb in CD4+ T cells stimulated with a-CD3-CD28.
(F) CFSE-labeled CD4+ T cells were stimulated with a-CD3-CD28 for 70 hr, pulsed with BrdU for 2 hr, and subjected to 7-AAD and BrdU staining. Presented is
BrdU staining of the gated CFSE-diluted population.
(G) WT and Rptorfl/fl CD4+ T cells were infected with EGFP-Cre retrovirus at 24 hr after a-CD3-CD28 stimulation, and 4 days later, GFP+ cells were sorted and
stimulated with a-CD3-CD28 for 24 hr for BrdU incorporation assay.
(H) WT CD4+ T cells were stimulated with a-CD3-CD28, and rapamycin was added at different time points (left panel). Cells were subjected to BrdU staining at
24 hr after addition of rapamycin. Data are representative of three (A, B, and H), one (C; n = 4 mice per group in the microarrays) or two (D–G) independent
experiments. See also Figure S3 and Tables S1 and S2.
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and Wells, 2006). We first stimulated CFSE-labeled T cells with
TCR ligation for 3 days and then analyzed CFSE-diluted
T cells, which represented cells that had entered cell cycle, for
BrdU incorporation. Although Rptor/ CD4+ T cells showed
less CFSE dilution, those that had diluted CFSE showed compa-
rable BrdU incorporation as WT counterparts (Figure 3F). Sec-
ond, we activated Rptor+/+ and Rptorfl/fl CD4+ T cells (lacking
the CD4-Cre transgene) to induce cell-cycle entry and then
deleted Raptor by transducing the cells with a retroviral vector
expressing Cre linked to EGFP (Figure S3D). We observed a
similar degree of BrdU incorporation of Rptor+/+EGFP-Cre+
and Rptorfl/flEGFP-Cre+ T cells stimulated with a-CD3-CD28
for 24 hr (Figure 3G). These results indicate that once T cells
enter cell-cycle, Raptor is not essential for their continuous
proliferation.
We therefore hypothesized that mTORC1mainly regulates the
exit from quiescence of naive T cells, rather than cell cycle
progression of activated cells. To test this idea, we inhibited
mTORC1 via rapamycin at different time points and performed
[3H]thymidine incorporation assay at 72 hr of TCR stimulation.
Rapamycin strongly inhibited T cell proliferation when added at
the time of TCR stimulation. However, it was much less effective
when added at later time points (Figure S3E), even though it
blocked S6K1 phosphorylation at all the time points examined
(Figure S3F). One potential caveat with this treatment regimen
was the differential durations of rapamycin in the culture. To
circumvent this, we added rapamycin at different times and
measured proliferation by BrdU incorporation always at 24 hr
after drug treatment. Consistent with the defect in Rptor/ cells
(Figure 3A), treatment of WT cells with rapamycin at the time of
TCR stimulation inhibited BrdU incorporation. In contrast, rapa-
mycin showed a much milder effect when added at 24 hr after
TCR stimulation and had no effect when added at 48 hr (Fig-
ure 3H). Similar effects were observed with the more potent
mTOR inhibitors Torin1 and PP242 (Benjamin et al., 2011) (Fig-
ure S3G). Altogether, Raptor-mTORC1 is critical for the transition
from quiescent G0 to S phase in naive T cells but becomes less
important once T cells have entered active cell cycle.
Raptor-mTORC1 Coordinates Multiple Metabolic
Programs in T Cell Activation
We explored the signaling and mechanistic basis underlying
Raptor functions in T cells. For TCR-induced signaling pathways,
phosphorylation of S6K1, S6, and 4E-BP1, the main targets of
mTORC1, was abolished in Rptor/ cells under both long-
and short-term TCR stimulation (Figures 4A and 4B). In contrast,
TCR-stimulation induced comparable phosphorylation of ERK
and IkBa, whereas phosphorylation of AKT at Ser473 was
modestly elevated in Rptor/ T cells (Figure 4B), in line with
the loss of mTORC1-mediated feedback inhibition of mTORC2
(Zoncu et al., 2011). These results indicate that Raptor deficiency
abolishes mTORC1 activity but does not cause global defects in
TCR signaling.
AlthoughmTORC1 has been implicated in activation of cellular
anabolic metabolism (Du¨vel et al., 2010), detailed mechanisms
are lacking; also, most evidence to date is derived from pharma-
cological inhibition. Among the plethora of metabolic pathways
important for rapidly proliferating cells is glycolysis (Wang and1048 Immunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier InGreen, 2012).We thereforemeasured whether Raptor deficiency
impairs TCR-induced glycolytic activity. WT CD4+ T cells mark-
edly upregulated glycolysis after TCR and CD28 stimulation (Fig-
ure 4C).Rptor/ T cells did not show difference fromWT cells at
the basal level, but TCR-induced upregulation was diminished at
24 hr after stimulation (Figure 4C). This was associated with
reduced messenger RNA (mRNA) expression of glycolytic en-
zymes including Hk2, Ldha, and Tpi1 (Figure 4D). Furthermore,
induction of protein but not mRNA expression of c-Myc, a crucial
transcription factor for T cell glycolysis (Wang et al., 2011), was
attenuated in Rptor/ cells (Figures 4E and 4F). These results
indicate an important role of Raptor in TCR-induced glycolysis.
We next tested the functional and temporal effects of blocking
glycolysis on T cell proliferation. The prototypical inhibitor of
glycolysis, 2-deoxyglucose (2-DG), inhibited T cell proliferation
when added to T cells at the time of activation (Figure S4A).
The antiproliferative effect of 2-DG was less obvious when
added at later time points (Figure S4A), even though it potently
inhibited T cell glycolytic activity at all the time points examined
(Figure S4B). Further, direct numeration of cultured cells also
indicated that 2-DG was more effective when added at early
than late time points of TCR stimulation (Figure S4C). These re-
sults recapitulated the findings from mTOR inhibitors described
above. Altogether, glucose metabolism activated by mTORC1
contributes to the transition from quiescence to proliferation.
We next performed gene ontology (GO) analysis to identify
additional metabolic pathways mediated by Raptor. All of the
top ten pathways altered at 8 hr of TCR stimulation (R2 fold)
were associated with the biosynthetic pathways of lipids (i.e.,
cholesterols and fatty acids), which were downregulated in
Rptor/ T cells (data not shown). The heat maps in Figure S4D
showed the defective induction of genes involved in lipogenic
pathways, many of which were verified by real-time PCR anal-
ysis (Figure S4E). These include genes in cholesterol synthesis
and uptake (Hmgcs1, Hmgcr, Idi1, Sqle, Dhcr24, and Ldlr), as
well as those in fatty acid synthesis, although the defects in the
latter group were less profound (Fasn) or occurred only at a later
time point (Scd1 and Scd2) (Figure S4E). To determine whether
these changes correlated with altered de novo lipid synthesis,
we measured the incorporation of [1-14C] acetate into chloro-
form- or methanol-soluble lipids. Rptor/ T cells were impaired
in TCR-induced de novo lipid synthesis (Figure 4G). The tran-
scription factors SREBP1 and SREBP2 are established regula-
tors of gene expression in lipid synthesis (Espenshade and
Hughes, 2007). TCR signals strongly upregulated protein
expression of SREBP1 and SREBP2, including the full-length
and processed mature forms. Deficiency of Raptor attenuated
both forms of these factors (Figure 4H). In contrast, mRNA
encoding SREBP1 and SREBP2 (Srebf1 and Srebf2) was not
affected by TCR stimulation regardless of Raptor sufficiency
(Figure 4I). Therefore, Raptor promotes the lipogenic program
and regulates SREBP functions through posttranscriptional
mechanisms.
We further employed GSEA analysis to directly compare
global gene expression between WT and Rptor/ T cells
at 8 hr of stimulation. Aside from glucose and cholesterol
metabolism (Figure S4F), oxidative phosphorylation was also
among the most significantly downregulated gene sets in






Figure 4. Raptor-mTORC1 Signaling Coordinates Glycolysis, Lipid Genesis and Oxidative Phosphorylation of Activated T Cells
(A and B) Phosphorylation of S6K1, S6, and 4E-BP1 (A) or AKT, 4E-BP1, ERK and IkBa (B) in CD4+ T cells stimulated with a-CD3-CD28.
(C) Glycolytic activity of CD4+ T cells stimulated with or without a-CD3-CD28 for 24 hr.
(D) Real-time PCR analysis of glycolytic genes in CD4+ T cells stimulated with a-CD3-CD28.
(E and F) Immunoblot (E) and real-time PCR analysis (F) of c-Myc expression in CD4+ T cells stimulated with a-CD3-CD28.
(G) De novo lipid biosynthesis of CD4+ T cells stimulated with or without a-CD3-CD28 for 24 hr.
(H) Expression of SREBP1 and SREBP2 full-length (Fl) and mature (M) forms in CD4+ T cells stimulated with a-CD3-CD28. Right panel shows densitometric
analysis of abundance of SREBP isoforms.
(I) Real-time PCR analysis of Srebf1 and Srebf2 mRNA in CD4+ T cells stimulated with a-CD3-CD28.
(J) Oxygen consumption rate (OCR) of CD4+ T cells stimulated with a-CD3-CD28 for 24 hr. Data are representative of two independent experiments, and error
bars represent the SEM. See also Figure S4.
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Figure 5. Raptor Deficiency Impairs Th2 Cell Differentiation In Vitro and Suppresses Allergic Airway Inflammation In Vivo
(A and B) T cells were cultured under Th2 conditions for 5–6 days, followed by intracellular staining of IL-4 and IFN-g upon PMA and ionomycin restimulation
(A, left), bioplex measurement of IL-4 secretion upon restimulation with a-CD3 for 24 hr (A, right), or real-time PCR analysis of Il4 and Il13mRNA expression upon
restimulation with a-CD3 for 5 hr (B).
(C) Intracellular staining of IL-4 in CFSE-labeled T cells cultured under Th2 conditions.
(D) Histopathology of lung in OVA-challenged mice. Left shows images of hematoxylin and eosin staining with 2 3 (upper) or 10 3 (bottom) of original magni-
fication. Right shows histological scores of the lung.
(E) Quantification of eosinophils (Eos), neutrophils (Neu), dendritic cells (DC), and T cells (T) in lung and BAL fluid from OVA-challenged mice (n = 4–7 mice per
group). NS, not significant.
(F) Intracellular staining of IL-4 in CFSE-labeledWTCD4+ cells cultured under Th2 conditions in the presence ofmock or rapamycin (50 nM) added at different time
points.
(G) Intracellular staining of IL-4 in CD4+ T cells cultured under Th2 conditions in the presence of mock or rapamycin (50 nM).
(H) Intracellular staining of IL-4 in CD4+ T cells cultured under Th2 conditions. Data are representative of three (A–C) or two (D–H) independent experiments, and
error bars represent the SEM. See also Figure S5.
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mTORC1 in Metabolic Programming of Quiescence Exitexpression, oxygen consumption rate (OCR) that denoted mito-
chondrial respiration was reduced in Rptor–/– T cells stimulated
with TCR and CD28 (Figure 4J). Collectively, Raptor is required
to regulate TCR-induced glycolysis, lipid biosynthesis and
oxidative phosphorylation. Given the recent evidence impli-
cating the importance of lipid synthesis and mitochondrial activ-
ity in T cell activation (Kidani et al., 2013; Sena et al., 2013), we
propose that coordination of these discrete metabolic programs
by mTORC1 orchestrates T cell activation and proliferation.
Further, the differential kinetics for the induction of metabolic
and cell-cycle genes at 8 and 24 hr (Tables S1 and S2) highlight
a Raptor-dependent temporal transition from metabolic reprog-
ramming to cell-cycle entry following TCR stimulation.1050 Immunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier InRaptor Is Crucial for Th2 Cell Differentiation
Having shown a central role of Raptor in programming metabolic
activities and quiescence exit that differentially impact cell-cycle
initiation and progression, we next explored the extent to which
this pathway was operative for subsequent T cell differentiation.
Previous studies have established a requirement of mTORC1 in
Th1 and Th17 cell differentiation (Delgoffe et al., 2011; Kurebaya-
shi et al., 2012), but loss of Rheb-dependent mTORC1 activity
does not impact Th2 cell development (Delgoffe et al., 2011).
However, we found that lack of Raptor markedly decreased
IL-4 production under Th2 conditions (Figure 5A), associated
with defective Il4 and Il13 mRNA expression (Figure 5B). CFSE
labeling showed that CFSElo Rptor/ cells, representative ofc.
A B
C D E F
G H
Figure 6. Raptor Links Glucose Metabolism to Cytokine Receptor Expression and Stat Activation for the Initiation of Th2 Cell Differentiation
(A) Intracellular staining of IL-4 in CFSE-labeled WT CD4+ cells cultured under Th2 conditions in the presence of mock or 2-DG added at the time of activation.
(B) Intracellular staining of IL-4 and IFN-g in WT CD4+ cells cultured under Th2 conditions in the presence of mock or 2-DG (0.3 mM) added at various times.
(C) Expression of IL-4Ra on CD4+ cells cultured under a-CD3-CD28 alone or Th2 conditions for 24 hr.
(D–F) Flow cytometry of Stat6 phosphorylation (D), IL-2Ra (E), and Stat5 phosphorylation (F) in CD4+ cells cultured under Th2 conditions for 24 hr.
(G) Expression of IL-4Ra on CD4+ cells cultured under Th2 conditions in the presence of mock, 2-DG, or rapamycin for 24 hr.
(H) Expression of IL-4Ra onCD4+ cells cultured under Th2 conditions in the presence of various doses of glucose.Mean fluorescent intensity (MFI) for the relevant
staining is presented above the plots (C–F). Data are representative of two (A, B, G, H) or three (C–F) independent experiments, and error bars represent the SEM.
See also Figure S6.
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(Figure 5C). Thus, Raptor function was essential for Th2 cell dif-
ferentiation in vitro, and this effect likely occurred independently
of, or in addition to, its role in cell proliferation.
To determine the role of Raptor in Th2 cell responses in vivo,
we immunized WT and Rptor/ mice with OVA and aluminum
hydroxide and then challenged them with OVA inhalation. In
this model of Th2 cell-dependent allergic airway disease, Raptor
deficiency diminished lung inflammation and infiltration of leuko-
cytes including eosinophils into the lung and bronchioalveolar
lavage (BAL) fluid (Figures 5D and 5E). For the few mutant
CD4+ T cells that had infiltrated into the lung, they had amarkedly
reduced ability for IL-4 production (Figure S5A). Furthermore, the
BAL fluid fromRptor/mice containedmarkedly reduced levels
of IL-4 and Th2-dependent IgE antibody (Figure S5B). These
results establish a central role of Raptor in Th2 cell responses
in vitro and in vivo.
We next determined the kinetic and signaling requirements for
Raptor-dependent cell-fate decisions. First, we found that rapa-
mycin treatment at the beginning of the culture profoundly dimin-
ished Th2 cell differentiation. This inhibitory effect was less
potent, although still evident, when rapamycinwas added at later
time points (Figure 5F). These results revealed the requirement
of a rapamycin-sensitive pathway, likely mTORC1, during the
quiescence exit period for shaping Th2 cell differentiation. How-Immever, because rapamycin also inhibits mTORC2 activity upon
chronic treatment (Delgoffe et al., 2011), an alternative interpre-
tation is that mTORC2 was targeted by rapamycin to influence
Th2 cell differentiation, a plausible notion based on the reported
roles of mTORC2 in this process (Delgoffe et al., 2011; Lee et al.,
2010). To test the contribution of mTORC2, we treated Rictor/
cells with rapamycin. Whereas loss of Rictor modestly (2-fold or
less) lowered Th2 cell differentiation, rapamycin exerted a
marked effect to further diminish IL-4 production from these cells
(Figure 5G). Furthermore, loss of both Raptor and Rictor caused
very little further reduction in IL-4 as compared with Raptor
deficiency alone (Figure 5H). These results illustrate the predom-
inant involvement of mTORC1 over mTORC2 in Th2 cell
differentiation.
mTORC1 Couples Glucose Metabolism to Cytokine
Responsiveness
Given a key role of Raptor in mediating T cell glycolysis and
lipogenesis, we tested whether the metabolic programs contrib-
uted to Th2 cell differentiation. Inhibition of glycolysis with 2-DG
had a strong effect to diminish Th2 cell differentiation in a dose-
dependent manner, which was evident even when cell prolifera-
tion was not affected (Figure 6A). Additionally, 2-DG treatment
at the beginning of differentiation was more effective to block
Th2 cell differentiation than at later time points of treatmentunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier Inc. 1051
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mTORC1 in Metabolic Programming of Quiescence Exit(Figure 6B). In contrast, 25-hydroxycholesterol (25-HC) had a
more modest effect on Th2 cell differentiation (Figure S6A),
even though it strongly inhibited T cell proliferation. Thus, among
the metabolic programs coordinately regulated by Raptor,
glucose metabolism appears to play a key role in Th2 cell
development.
We further investigated the downstream mechanisms by
which mTORC1-dependent metabolism impinges upon Th2
cell differentiation. Development of effector T cells requires the
induction of cytokine receptors that in turn confers enhanced
responsiveness to cytokines to potentiate T cell differentiation
in a feedforward manner (Zhu et al., 2010). Rptor/ T cells
were impaired to induce IL-4Ra upon stimulation with a-CD3-
CD28 or under Th2 cell-polarizing conditions, whereas Rictor/
cells showed largely normal IL-4Ra induction (Figure 6C).
Further, Rptor/Rictor/ T cells showed a similar defect in
IL-4Ra induction as Rptor/ cells (Figure S6B). Consistent
with the defective IL-4Ra expression, Rptor/ T cells were
unable to efficiently phosphorylate Stat6 under Th2 cell condi-
tions (Figure 6D). In addition to IL-4, Th2 cell differentiation is
also contingent on IL-2 signaling (Zhu et al., 2010). Indeed,
Rptor/ T cells exhibited impaired induction of IL-2Ra (Fig-
ure 6E), as well as downstream Stat5 activation (Figure 6F). In
contrast, expression of other receptors such as CD122 (IL-
2Rb), CD132 (gc), CD44, and CD69 was largely undisturbed in
the mutant cells (Figure S6C). Also, Rptor/ cells expressed
the Th2 factor GATA3 at a lower level than WT cells at 24 hr of
Th2 cell differentiation (Figure S6D), although this impairment
did not persist at later times (data not shown). Therefore,
mTORC1 is important for the induction of selective cytokine re-
ceptors that likely mediate the enhanced responsiveness to
Th2-polarizing cytokines, thereby programming initiation of Th2
cell differentiation.
Are these effects on cytokine receptor expression dependent
upon T cell metabolism? To address this, we used selective
metabolic inhibitors andmeasured induction of IL-4Ra. Inhibition
of glucose metabolism by 2-DG or of mTOR activity by
rapamycin lowered induction of IL-4Ra (Figure 6G). In contrast,
25-HC did not exert strong effects on IL-4Ra expression
(Figure S6E). Similarly, rapamycin and 2-DG but not 25-HC
inhibited the induction of IL-2Ra (Figures S6E and S6F). We
then explored whether cytokine receptor induction is dependent
upon glucose levels in the culture medium. Indeed, lowering
glucose levels markedly reduced the expression of IL-4Ra (Fig-
ure 6H). We conclude that mTORC1-dependent glucose meta-
bolism contributes to cytokine receptor expression for Th2 cell
differentiation.
Raptor Integrates TCR and CD28 Signals for T Cell
Activation and Differentiation
We investigated upstream signals that activate mTORC1-
dependent metabolism in Th2 cell differentiation. First, we
measured glycolytic activity in a-CD3-activated T cells supple-
mented with Th2-polarizing cytokines IL-2 and IL-4 but found
that these cytokines had little effect on glucose metabolism (Fig-
ure 7A). In contrast, CD28 costimulation markedly potentiated
glycolysis (Frauwirth et al., 2002) (Figure 7A) and also enhanced
T cell growth, upregulation of nutrient receptors, and lipid syn-
thesis in TCR-stimulated cells (Figure S7A). Second, we deter-1052 Immunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier Inmined whether CD28 costimulation influencedmTORC1 activity.
CD28 had little effects on TCR-induced mTORC1 activation at
early time points (Figure S7B), but it potently enhancedmTORC1
after 18 hr of stimulation as comparedwith TCRalone (Figure 7B).
Thus, CD28 acts in synergy with TCR to potentiate T cell meta-
bolism and sustain mTORC1 activation.
To further explore the signaling mechanisms, we determined
whether Rheb is involved by directly comparing the effects of
Rheb and Raptor deficiencies on T cell activation, Th2 cell
differentiation, and mTORC1 activity. As compared with the
profound defects in T cell proliferation and Th2 cell differentia-
tion in Rptor/ cells, Rheb/ cells exhibited much milder
defects in cell-cycle entry (Figure 7C) and proliferation (Figures
S7C and S7D) and normal Th2 cell differentiation (Delgoffe
et al., 2011) (Figure 7D). Further, whereas Raptor deficiency
abrogated phosphorylation of 4EBP1, S6K1, and S6 at all the
time points, loss of Rheb blocked mTORC1 activation only
at early time of TCR stimulation, but the activity largely recov-
ered at 18 hr (Figure 7E). Thus, Rheb is not essential for
sustained mTORC1 activation induced by TCR and costimu-
lation. We next investigated whether mTORC2 activity is
involved in this process. Loss of Rictor ablated AKT Ser473
phosphorylation but had no effect on mTORC1 activation (Fig-
ure 7F), consistent with previous observations (Lee et al., 2010).
Altogether, Raptor-mediated mTORC1 activation integrates
TCR and CD28 costimulation for T cell responses (Figure S7E),
and this process can be regulated independently of Rheb or
mTORC2.
DISCUSSION
Antigen-induced clonal expansion is a hallmark of adaptive
immunity, but little is known how this process is initiated, namely
how naive T cells respond to antigens by transitioning from pro-
grammed quiescence into active cycling. Here we describe a
pathway in which Raptor-dependent mTORC1 activation and
metabolic reprogramming drive the exit of T cells from quies-
cence, and this in turn coordinates T cell activation and fate
decisions. Mechanistically, Raptor-mTORC1 orchestrates cell
metabolism, especially the glycolytic and lipogenic programs,
to facilitate the entry into an active cell cycle. Further, this
pathway is intimately linked to fate decisions, as deficiency of
Raptor or blocking glucose metabolism prevents the generation
of Th2 cells. Direct comparisons of phenotypic alterations in
T cells lacking Raptor with those deficient in Rheb or Rictor
highlight an unexpected, predominant contribution of Raptor-
mTORC1 to T cell activation and Th2 cell differentiation. We
propose that Raptor-dependent metabolic reprogramming and
quiescence exit are a fundamental determinant that underlies
specific proliferative and differentiative responses in adaptive
immunity.
Our results highlight that quiescence exit is an intermediate
state connecting early TCR signaling (e.g., NF-kB and MAPK
activation) and cell-cycle entry, marked by mTORC1-dependent
extensive metabolic reprogramming. However, mTORC1 is less
crucial for continuous proliferation. The simplest interpretation is
that cell-cycle entry of naive T cells has a stringent requirement
of metabolic activities. Once T cells have entered active cycling,




Figure 7. Raptor but Not Rheb Is Essential for TCR and CD28-Induced Sustained mTORC1 Activation and Physiological Effects
(A) Glycolytic activity of WT CD4+ T cells stimulated with a-CD3 or a-CD3-CD28 in the presence of IL-2, IL-4, or both for 24 hr.
(B) Phosphorylation of S6K1, S6, and 4E-BP1 in WT CD4+ T cells stimulated with a-CD3 or a-CD3-CD28.
(C) BrdU staining of CD4+ T cells stimulated with a-CD3-CD28 for 22 hr, followed by pulsing with BrdU for 2 hr.
(D) Intracellular staining of IL-4 and IFN-g in CD4+ T cells cultured under Th2 conditions.
(E) Phosphorylation of 4E-BP1, S6K1, and S6 in CD4+ T cells stimulated with a-CD3 or a-CD3-CD28.
(F) Phosphorylation of S6K1, 4E-BP1, and AKT Ser473 in CD4+ T cells stimulated with a-CD3 or a-CD3-CD28. Data are representative of one (A) or two (B-F)
independent experiments, and error bars represent the SEM. See also Figure S7.
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pathways when mTORC1 is inhibited. Despite this, the delay in
quiescence exit in Rptor–/– cells is functionally important
because this essentially cripples adaptive immunity. These
studies have established a critical cellular context whereby
mTORC1-dependent metabolism promotes cell proliferation.
Further, mTORC1 activated within the first 24 hr makes a
profound contribution to Th2 cell differentiation, highlighting
mTORC1-mediated quiescence exit as a central mechanism in
T cell activation and fate decisions.
For T cell differentiation, much of the recent emphasis has
been placed on cytokine receptor signaling. In contrast, the
mechanisms by which costimulation shapes T cell fates are
poorly understood, despite earlier studies implicating their func-
tional significance (Corry et al., 1994). Moreover, relatively little is
known about the initiation phase of T cell differentiation (Yamane
and Paul, 2013). Here we show that Raptor-mTORC1 integrates
TCR and CD28 signals and links them to T cell metabolism and
cytokine responsiveness as an important mechanism to pro-
gram Th2 cell differentiation. Deletion of Raptor or blocking glu-
cose metabolism impairs proper differentiation into Th2 effectorImmcells, associated with defective cytokine receptor expression
and Stat activation. As for the stringent requirement of this
pathway for Th2 cell differentiation, it is important to note
that Th2 cell differentiation is metabolically demanding in that
Th2 cells have the highest rate of glycolysis among all effector
T cells examined (Michalek et al., 2011; Shi et al., 2011). Further-
more, effector cytokine expression, especially IL-4 from Th2
cells, is cell-cycle-dependent (Bird et al., 1998). Whereas
our finding certainly does not exclude the contribution of
mTORC1-dependent proliferation to Th2 cell differentiation,
Raptor deficiency impairs multiple processes required for Th2
cell generation at 24 hr of activation, before the first cell division.
Additionally, Rptor/ cells that have undergone division
(CFSElo) cells are capable of continuous division but not for
IL-4 production. Furthermore, 2-DG inhibits Th2 cell differen-
tiation, even at doses without affecting cell proliferation.
Altogether, we propose that Raptor-mediated metabolic re-
programming is an underlying mechanism to couple proliferation
and Th2 cell differentiation, thereby placing metabolic fitness
as a key upstream determinant to coordinate both processes
(Figure S7E).unity 39, 1043–1056, December 12, 2013 ª2013 Elsevier Inc. 1053
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independent of Rheb, in agreement with a previous report (Del-
goffe et al., 2011). We also noted that deletion of Raptor is
more detrimental for embryonic and brain development than
Rheb deficiency (Cloe¨tta et al., 2013; Goorden et al., 2011; Guer-
tin et al., 2006; Zou et al., 2011). These studies suggest the exis-
tence of functional redundancy in the GTPases or the presence
of alternative pathways for mTORC1 activation. Although
mTORC2 contributes to Th2 cell differentiation (Delgoffe et al.,
2011; Lee et al., 2010), we show that it plays a more modest
role than Raptor. Further, loss of Rictor has little effect on the
activation of mTORC1 or IL-4Ra expression in T cells. Moreover,
AKT activity is required for Th1 but not Th2 cell differentiation
(Kane et al., 2001). Altogether, these results indicate the pres-
ence of upstream inputs independent of Rheb, mTORC2, or
AKT for the activation of mTORC1 and Th2 cell differentiation.
We speculate that this could involve the PI3K-AKT-independent
pathway for mTORC1 activation in activated CD8+ T cells that is
mediated by the kinase PDK1 (Finlay et al., 2012; Macintyre
et al., 2011) and/or amino acid uptake (Sinclair et al., 2013).
Future work is required to identify the nature of such signals in
CD4+ T cell responses.
Emerging evidence points to an important role for metabolic
control of T cell functions and fates orchestrated by transcrip-
tion factors (Wang and Green, 2012). However, there is little
genetic evidence linking mTOR to T cell metabolism. Here we
have identified a central role of Raptor-mTORC1 in coordi-
nating multiple metabolic pathways, including glycolysis, lipid
synthesis, and oxidative phosphorylation. This is accompanied
by dynamic transcriptional induction of metabolic enzymes and
posttranslational regulation of key transcription factors in-
cluding c-Myc and SREBPs. A similar requirement for mTORC1
in glycolysis and lipogenesis has been shown in growth factor-
independent proliferation of mouse embryonic fibroblasts
(Du¨vel et al., 2010). However, the effector mechanisms
downstream of mTORC1 are distinct, which could reflect phys-
iologically programmed quiescence and signal-dependent exit
that are unique to lymphocytes. Further, our recent studies
have established a crucial role of mTORC1-dependent lipo-
genic pathway in establishing regulatory T cell function (Zeng
et al., 2013). These findings collectively highlight cell context-
specific regulation and function of mTORC1-dependent meta-
bolic network.
In summary, our study has identified a key role of mTORC1-
mediated metabolic reprogramming for mediating T cell exit
from quiescence that in turn impacts T cell proliferation and
fate decisions. Although metabolic upregulation is generally
thought to support the high rate of cell proliferation, our
results suggest that mTORC1-dependent metabolism is more
important for the exit from quiescence and initiation of the
cell cycle, i.e., the ‘‘competence’’ to enter this high rate of
expansion, rather than maintaining the high rate of active
proliferation. Moreover, the initial metabolic reprogramming
has a crucial role in imprinting the ensuing fate decisions.
We propose that the unique metabolic requirement of
quiescence exit defines one of the major cellular events con-
necting early signals from TCR and costimulation and subse-
quent proliferative and differentiative responses in adaptive
immunity.1054 Immunity 39, 1043–1056, December 12, 2013 ª2013 Elsevier InEXPERIMENTAL PROCEDURES
Mice
C57BL/6, CD45.1+, OT-II, and Rag1–/– mice were purchased from the Jackson
Laboratory. Rptorfl, Rictorfl, and CD4-Cre mice have been described (Yang
et al., 2011; Zeng et al., 2013). The generation of Rheb floxed mice will be
described elsewhere. All mice were kept in specific pathogen-free conditions
in Animal Resource Center at St. Jude. Animal protocols were approved by
Institutional Animal Care and Use Committee of St. Jude.
Cell Purification and Cultures
Sorted naive T cells (CD4+CD62LhiCD44loCD25–) were used for in vitro cultures
in Click’s medium supplemented with b-mercaptoethanol, 10% FBS, and 1%
penicillin-streptomycin. For Th2 cell differentiation, naive T cells were acti-
vated with a-CD3 (2C11; 2 mg/ml), a-CD28 (37.51; 2 mg/ml), human IL-2
(100 U/ml), IL-4 (10 ng/ml), a-IFN-g (10 mg/ml), and irradiated splenocytes as
antigen-presenting cells. Live cells were collected by Ficoll purification after
5–6 days of differentiation and restimulated with PMA and ionomycin for intra-
cellular staining or with anti-CD3 for mRNA and bioplex analysis. To measure
cytokine receptors and transcription factors at early time point (24 hr), we stim-
ulated naive T cells (CD45.2+) as above except in the presence of irradiated
splenocytes (CD45.1+) to unequivocally identify T cells. To alter glucose
concentrations, we cultured T cells under Th2 conditions in glucose-free
DMEM medium, 10% dialyzed FBS and various doses of glucose. To obtain
protein extracts used for immunoblots, we incubated T cells with biotinylated
a-CD3-CD28 followed by crosslinking streptavidin for short-term stimulation
or stimulated with plate-bound a-CD3-CD28 for long-term stimulation. Retro-
viral transduction of T cells was performed as described previously (Liu et al.,
2010).
Metabolic Assays
CD4+ T cells were stimulated with plate-bound a-CD3-CD28 for 24 hr, and
glycolytic flux was measured by detritiation of [3-3H]-glucose, as previously
described (Shi et al., 2011). De novo lipid synthesis was determined as
described (Du¨vel et al., 2010; Zeng et al., 2013). Briefly, for the final 4 hr of cul-
ture, [1-14C] acetate (Perkin Elmer) was added to the cells. Cells were lysed in
0.5% Triton X-100, and the lipid fraction was extracted by addition of
chloroform andmethanol (2:1 v/v) with vortexing, followed by addition of water
with vortexing. After centrifugation, the lipid-containing phase was obtained
and 14C incorporation was measured with a Beckman LS6500 scintillation
counter. The OCR rate was measured with the Seahorse XF24-3 extracellular
flux analyzer per manufacturer’s instructions (Seahorse Bioscience).
Statistical Analysis
p values were calculated with Student’s t test. p values of less than 0.05 were
considered significant.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE51668.
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